News

A retinal surgeon describes a new scleral buckling device which requires less surgical dissection, has a one or two-stitch fixation, is applicable to treat pathology over 4 clock hours in any quadrant, and which can be removed in the office 3 to 4 weeks after insertion.

An examination of the advancements made in drug therapy this past year includes ocular surface therapy, the approval of an anti-inflammatory mydriatic agent, and several dry eye drugs.

With a wide array of IOL options available to their foreign colleagues, U.S. ophthalmologists eagerly await the approval and availability of additional lenses.

Taking a look at the improvements made this past year in refractive accuracy through several new technologic evolutions.

Politicians rarely tell the truth, so why should ophthalmologists . . . right?

Not all orbital fractures need to be repaired, and not all fractures need to be repaired early after the patient sustains an insult. However, early repair of orbital factures can be beneficial for some patients. Ferreting out who those patients involves some special consideration.

Findings evaluating the incidence of posterior vitreous detachment on quality of vision and reading speed have been released.

A proof-of-concept trial was launched to determine the safety and efficacy of squalamine lactate ophthalmic solution in eyes with macular edema secondary to branch and central retinal vein occlusion.

Using the most recent nomogram for intrastromal astigmatic keratotomy using a proprietary femtosecond laser platform, the mean vector magnitude achieved was 87%.

Iridex has been awarded a competitive tender for more than $350,000 in ophthalmology laser equipment by the government of Zambia.

NASA has struggled to understand why many astronauts, upon returning from space missions, have experienced moderate to severe eye problems and changes to their vision, said Dorit Donoviel, PhD.

Valeant Pharmaceuticals International has acquired Nicox S.A.’s U.S. diagnostics subsidiary, Nicox, Inc., in a deal worth up to $20 million.

This collection of documents demonstrates the love and admiration that these distinguished individuals, all of whom are highly respected in the history of ophthalmology, have held for one another.

Seanna Grob MD, MAS, and Reza Dana, MD, MPH, MSc, present the second-place winning entry in Ophthalmology Times' Resident Writer's Award Program, sponsored by Allergan. In this case presentation, the treatment of dry eye disease in the setting of GVHD is a complicated condition that can have devastating effects if not diagnosed and treated in a timely fashion. Patients require close monitoring by an experienced cornea specialist and often need a combination of multiple available treatments to control symptoms and disease progression.

An examination on accountable care organizations and how they may impact ophthalmology.

To make the most of the limited time for seeing patients, it helps to structure visits for dry eye disease following a plan that addresses diagnosis, testing, education, and treatment, but also taps technology to improve efficiency and help patients find reliable information.

Should ophthalmologists be required to take courses on marijuana?

The Cliradex Complete Advanced Lid Hygiene Kit is a new product that may help manage symptoms of lid margin diseases. The kit’s Cliradex Advance Care gel-whose main component is 4-Terpineol-has a miticidal effect and cleansing properties that can help improve ocular health.

A new intraocular mini-telescope is easy to implant through a small incision and has optimized optics so that it reliably provides good quality vision.

George O. Waring IV, MD, FACS, discusses how the ability to evaluate quality of vision by assessing forward light scatter of the dysfunctional lens, measure depth-of-focus, guide in centration, and functionally evaluate unstable tear film to diagnose dysfunctional tear syndrome have made an advanced diagnostic/surgical planning device invaluable in practice.

Advances to an imaging technology may assist clinicians in improving a diagnosis of meibomian gland dysfunction with objective examination of patients’ tear film lipid layer, blink profile, and meibomian gland structure and function.

A therapeutic in development blocks interleukin-1-a major player in the initiation and maintenance of the inflammatory response-and may help patients with moderate to severe dry eye disease.

A line of products used for the temporary relief of burning and irritation caused by dry eye was shown to increased meibomian gland function from baseline compared with warm compresses.

A recent study demonstrates the importance of evaluating osmolarity during cataract surgical planning in order to ensure that presurgical keratometry readings are not compromised by hyperosmolarity of the ocular surface.

In the second of a two-part series, Arun C. Gulani, MD, reviews how to address lens-based surgeries when they are associated with previous radial keratotomy (RK). In the second of a two-part series, Arun C. Gulani, MD, reviews how to address lens-based surgeries when they are associated with previous radial keratotomy (RK).

Clinical study demonstrates impressive symptom relief for patients with evaporative dry eye disease

The first clear formulation of cyclosporine A 0.05% (CyclaSol, Novaliq) demonstrated excellent safety and tolerability in a phase I study.

A metabolomics study found a link between dry eye disease and androgen metabolism in females.